ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,949,134 | +1.9% | 10,133 | -2.5% | 0.06% | -3.3% |
| Q1 2023 | $3,874,087 | -1.6% | 10,398 | 0.0% | 0.06% | -7.6% |
| Q4 2022 | $3,939,074 | +6.8% | 10,398 | -0.5% | 0.07% | +3.1% |
| Q3 2022 | $3,689,000 | -8.3% | 10,448 | -1.6% | 0.06% | -1.5% |
| Q2 2022 | $4,025,000 | +17.9% | 10,623 | -1.9% | 0.06% | +35.4% |
| Q1 2022 | $3,414,000 | -47.3% | 10,828 | -41.5% | 0.05% | -40.7% |
| Q4 2021 | $6,479,000 | +14.4% | 18,500 | -1.3% | 0.08% | +2.5% |
| Q3 2021 | $5,661,000 | +1.5% | 18,745 | +1.2% | 0.08% | +1.3% |
| Q2 2021 | $5,578,000 | +14.3% | 18,528 | +4.5% | 0.08% | +2.6% |
| Q1 2021 | $4,881,000 | -13.9% | 17,725 | -8.0% | 0.08% | -17.4% |
| Q4 2020 | $5,666,000 | +8.2% | 19,267 | -3.4% | 0.09% | -5.2% |
| Q3 2020 | $5,235,000 | +639.4% | 19,940 | +534.0% | 0.10% | +592.9% |
| Q2 2020 | $708,000 | – | 3,145 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |